Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox

Title: Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox
Creator: Deng, Lucy; Lopez, Laura K.; Glover, Catherine; Cashman, Patrick; Reynolds, Renee; Macartney, Kristine; Wood, Nicholas
Relation: JAMA - Journal of the American Medical Association Vol. 329, Issue 23, p. 2091-2094
Publisher Link: http://dx.doi.org/10.1001/jama.2023.7683
Publisher: American Medical Association
Resource Type: journal article
Date: 2023
Description: In response to a global shortage of modified vaccinia Ankara–Bavarian Nordic (MVA-BN) vaccines, Australia adopted a dose-sparing schedule for the recent mpox outbreak, with 0.1-mL intradermal MVA-BN vaccine recommended for preexposure and 0.5-mL subcutaneous vaccine for postexposure prophylaxis, 2 doses given 4 weeks apart.1 To understand the adverse events profile of MVA-BN vaccine, data were analyzed on adverse events after subcutaneous and intradermal MVA-BN collected by Australia’s vaccine safety surveillance system, AusVaxSafety.2
Subject: immunization; vaccinia; global shortage; Australia
Identifier: http://hdl.handle.net/1959.13/1498256
Identifier: uon:54499
Identifier: ISSN:0098-7484
Language: eng
Reviewed

		Thumbnail	File	Description	Size	Format